Where Will ProPhase Labs Inc (PRPH) Stock Go Next After It Is Up 13.39% in a Week?

ProPhase Labs Inc (PRPH) stock has risen 13.39% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

ProPhase Labs Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PRPH!

See Full PRPH Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With PRPH Stock Today?

ProPhase Labs Inc (PRPH) stock is trading at $9.82 as of 3:23 PM on Friday, May 26, a rise of $0.56, or 6.05% from the previous closing price of $9.26. The stock has traded between $9.15 and $9.88 so far today. Volume today is 71,031 compared to average volume of 81,489. To screen for more stocks like ProPhase Labs Inc click here.

More About ProPhase Labs Inc

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services. Click Here to get the full Stock Report for ProPhase Labs Inc stock.